Negotiators Prioritize Generic And Biosimilar Oncology Medicines Over Newer Drugs
UICC And WHO Will Bargain For Cheaper Cancer Drugs For LMICs
Executive Summary
The Union for International Cancer Control and the World Health Organization are prioritizing off-patent drugs in their efforts to facilitate oncology medicine access in developing nations.